Maternal Vaginal Fluids Mimic Microbe Transfer of Vaginal Birth

Swabbing infants born by Cesarean-section with a gauze harboring their mother’s vaginal fluids made their skin and gut microbiota more closely resemble that of vaginally born babies.

Written byAlejandra Manjarrez, PhD
| 4 min read
a newborn C-section baby in the gloved hands of doctors

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: An infant delivered via C-section
© ISTOCK.COM, 1905HKN

Babies born by C-section carry an increased risk of immune and metabolic disorders later in life, which studies have suggested may be associated with the communities of microbes on and in their bodies at the time of birth. The diversity of microbes hosted by Cesarean-born babies differs from that of those born by vaginal delivery, a difference that may arise because vaginally born neonates are colonized by microbes as they pass through the birth canal. According to a paper published June 17 in Med, this natural colonization event could be mimicked by swabbing Cesarean-delivered newborns with a gauze soaked with their mothers’ vaginal fluids. The skin and gut bacteria of C-section babies treated with this procedure were more similar to vaginally delivered babies, at least during their first year of life, than those not exposed to vaginal fluids.

A pilot study by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • alejandra manjarrez

    Alejandra Manjarrez is a freelance science journalist who contributes to The Scientist. She has a PhD in systems biology from ETH Zurich and a master’s in molecular biology from Utrecht University. After years studying bacteria in a lab, she now spends most of her days reading, writing, and hunting science stories, either while traveling or visiting random libraries around the world. Her work has also appeared in Hakai, The Atlantic, and Lab Times.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies